Lowey Dannenberg has joined other law firms in investigating potential securities violations after a former executive alleged Alignment misclassified operating costs as capital expenditures, inflating adjusted EBITDA.
Alignment Healthcare, Inc. shares fell sharply on July 8, 2026 after reports said a former executive had filed a whistleblower complaint accusing the company of accounting irregularities that artificially inflated previously reported and projected financial results. The allegations center on adjusted EBITDA, a key non-GAAP metric, with the complaint saying $8 million to $10 million in routine operating expenses were misclassified as capital expenditures. The stock dropped $4.02, or 16.7%, to close at $20.03. Lowey Dannenberg P.C. has now said it is investigating potential federal securities law violations, adding to earlier investor-law-firm scrutiny of the company.